SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-006192
Filing Date
2021-08-27
Accepted
2021-08-27 08:47:23
Documents
16
Period of Report
2021-08-26
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_082721.htm   iXBRL 8-K 58142
2 EXHIBIT 3.1 exh_31.htm EX-3.1 15288
3 EXHIBIT 99.1 exh_991.htm EX-99.1 23426
4 EXHIBIT 99.2 exh_992.htm EX-99.2 23513
8 GRAPHIC logo.jpg GRAPHIC 10260
  Complete submission text file 0001171843-21-006192.txt   334256

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE acst-20210826.xsd EX-101.SCH 3000
6 XBRL LABEL FILE acst-20210826_lab.xml EX-101.LAB 34915
7 XBRL PRESENTATION FILE acst-20210826_pre.xml EX-101.PRE 22772
9 EXTRACTED XBRL INSTANCE DOCUMENT f8k_082721_htm.xml XML 3980
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 211214253
SIC: 2834 Pharmaceutical Preparations